What Are the Top Cannabis Stocks by Market Cap?

The cannabis industry's market capitalization landscape is dominated by several key players, though valuations fluctuate significantly due to market volatility and regulatory changes. As of recent data, the top cannabis stocks by market cap include: **Canopy Growth Corporation (CGC)** typically ranks among the largest, with market caps that have ranged from $1-4 billion depending on market conditions. The Canadian company operates across multiple international markets and has strategic partnerships with major corporations. **Tilray Brands (TLRY)** following its merger with Aphria, represents one of the largest cannabis companies globally, with market caps generally ranging from $800 million to $2.5 billion. The company operates in both medical and adult-use markets across Canada, Europe, and other regions. **Cronos Group (CRON)** maintains significant market presence with backing from Altria Group, typically maintaining market caps between $500 million to $1.5 billion. **Aurora Cannabis (ACB)** despite facing challenges, remains a major player with market caps fluctuating between $200 million to $1 billion. **U.S. Multi-State Operators (MSOs)** like Curaleaf Holdings (CURLF), Green Thumb Industries (GTBIF), and Trulieve Cannabis (TCNNF) represent significant value but trade on over-the-counter markets due to federal cannabis prohibition, with combined market caps often exceeding $10 billion. **Important Considerations:** Cannabis stock valuations are highly volatile due to regulatory uncertainty, changing state laws, and federal prohibition in the United States. Market caps can shift dramatically based on earnings reports, policy changes, and market sentiment. Investors should note that cannabis stocks carry significant risks including regulatory changes, market competition, and operational challenges. These rankings change frequently, and past performance doesn't guarantee future results. *Disclaimer: This information is for educational purposes only and should not be considered investment advice. Cannabis investments carry substantial risks.*